Eli Lilly and Company announced that Alonzo Weems, executive vice president of enterprise risk management and chief ethics and compliance officer, and a member of Lilly's Executive Committee, will retire after 27 years of service with the company, effective Dec. 31, 2024. Weems will continue to serve in his role while the company conducts an internal and external search for a chief ethics and compliance officer.

Weems began his Lilly career in 1997 as an attorney in the global medical and regulatory affairs legal group. Throughout his career, he has held important leadership roles, including general counsel for Lilly Canada, general counsel for Lilly USA and the Biomedicines and Diabetes business units, and vice president and deputy general counsel for the corporate legal functions prior to assuming his current role. Ethisphere recognized Lilly as one of the World's Most Ethical Companies for the eighth year in a row in 2024, underscoring Weems' pivotal role in championing sustained excellence in ethical practices across the organization.